Di Nuzzo Private Wealth, Inc. Exact Sciences Corp Transaction History
Di Nuzzo Private Wealth, Inc.
- $697 Million
- Q3 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 11 shares of EXAS stock, worth $736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 19
42.11%
Holding current value
$736
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EXAS
# of Institutions
660Shares Held
158MCall Options Held
1.43MPut Options Held
2.35M-
Capital World Investors Los Angeles, CA18.2MShares$1.22 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$808 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$804 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$360 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...